Not Tagged
Castle Biosciences
[]
$cstl - late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx -scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort study 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.